BODUNZY

Serial Number 98514337
688

Registration Progress

Application Filed
Apr 23, 2024
Under Examination
Mar 25, 2025
Approved for Publication
Jan 28, 2025
Published for Opposition
Jan 28, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Sep 25, 2025 78 days

Basic Information

Serial Number
98514337
Deadline
September 25, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
April 23, 2024
Published for Opposition
January 28, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 25, 2025
Application
Pending
Classes
005

Rights Holder

Sun Pharmaceutical Industries Limited

16
Address
Western Express Highway, Goregaon (E)
Sun House, Plot No. 201 B/1
Mumbai, Maharashtra 400063
IN

Ownership History

Sun Pharmaceutical Industries Limited

Original Applicant
16
Mumbai, Maharashtra IN

Sun Pharmaceutical Industries Limited

Owner at Publication
16
Mumbai, Maharashtra IN

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Deadline
78 days remaining
NOA E-Mailed - SOU Required
Due Date
September 25, 2025
Extension Available
Until March 25, 2026

Application History

14 events
Date Code Type Description
Mar 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 2, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 17, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2024 CNRT R NON-FINAL ACTION WRITTEN
Oct 7, 2024 GNRT F NON-FINAL ACTION E-MAILED
Sep 29, 2024 DOCK D ASSIGNED TO EXAMINER
Apr 23, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention of breast cancer in post-menopausal women; Pharmaceutical preparations for the prevention of bone and skeletal diseases

Classification

International Classes
005